Science and politics in the regulation of human embryonic stem-cell research in Brazil

2014 ◽  
Vol 54 (1) ◽  
pp. 3-22 ◽  
Author(s):  
Maya Mitre ◽  
Bruno P.W. Reis

This case study deals with the regulation of human embryonic stem-cell (hESC) research in Brazil. It aims to analyze the process that led to the authorization, in 2005, of the use of stem cells obtained from so-called supernumerary embryos for purposes of research and therapy. We argue that the pro-research lobby in Brazil had considerable success because it framed the issue by referring to Brazil’s peculiar policy background in the fields of assisted reproduction and embryo research. Moreover, this group of actors strategically avoided associating hESC research with abortion, highlighting the humanitarian aspects of this kind of research, rather than the motto of freedom of scientific research. Finally, it was able to rely on the judgment of a fairly progressive Supreme Court, which was also sensitive to public opinion at a time of ‘court activism’ or the ‘judicialization of politics’ in Brazil.

2009 ◽  
Vol 22 (2) ◽  
pp. 31-54
Author(s):  
Françoise Baylis ◽  
Timothy Krahn

In an effort to quell ongoing debate about the ethics of human embryonic stem cell (hESC) research, there have been concerted efforts to develop ethical standards for both embryo and hESC research and to entrench these standards in law. Surprisingly these efforts have not included efforts at standardizing the meaning of the pivotal term ‘embryo’. This paper reviews the legal framework for embryo research in the United Kingdom, the United States and Germany and highlights the absence of any agreed upon standard for what counts as a human embryo. This is an important lacuna, especially in light of the most recent advances in stem cell research involving the reprogramming of human somatic cell nuclei to generate human induced pluripotent stem (iPS) cells.


Sign in / Sign up

Export Citation Format

Share Document